The efficacy and safety of carbomer treatment oral mucositis caused by radiotherapy with head and neck cancer patients
Jianjun Shen,Weina Niu,Hongyan Zhang,Weiwei Wu
DOI: https://doi.org/10.3969/j.issn.1672-4992.2018.10.007
2018-01-01
Journal of Modern Oncology
Abstract:Objective:To evaluate the efficacy and safety of carbomer treatment oral mucositis caused by radiother-apy with head and neck cancer patients.Methods:With physiological saline as control,using the visual marking meth-od(VAS)recorded pain intensity of three meals,at the same time recorded the degree of weight loss before and after radiotherapy,oral acidity and inflammation of the oral mucosa.Results:The VAS of breakfast,lunch and dinner car-bomer group were 0.67 ± 1.11,0.69 ± 1.12,0.74 ± 1.14,normal saline group were respectively -0.31 ± 1.20,-0.32 ± 1.15,-0.31 ± 1.23(P<0.000 1).Carbomer group before and after weight loss degree was(1.24 ± 2.17)kg,normal saline group was(2.09 ± 2.35)kg(P=0.004 4).Carbomer group difference before and after oral pH value is-0.21 ± 0.64,normal saline group was -0.28 ± 0.56(P= 0.342 9).Carbomer group before and after oral mucositis classification difference was 1.09 ± 0.85,normal saline group was 0.22 ± 1.13(P=0.000 0). Conclusion:Carbomer can relieve pain and classification of inflammation of radioactive oral cavity mucous mem-brane,reduce weight loss during radiation therapy.Carbomer was safe and effective in the treatment oforal cavity mu-cous.
What problem does this paper attempt to address?